Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

Dmitry I. Gabrilovich, Hailei L. Chen, Khaled R. Girgis, H. Thomas Cunningham, Geralyn M. Meny, Sorena Nadaf, Denise Kavanaugh, David P. Carbone

Research output: Contribution to journalArticle

1330 Citations (Scopus)

Abstract

Inadequate presentation of tumor antigens by host professional antigen-presenting cells (APCs), including dendritic cells (DCs), is one potential mechanism for the escape of tumors from the host immune system. Here, we show that human cancer cell lines release a soluble factor or factors that dramatically affect DC maturation from precursors without affecting the function of relatively mature DCs. One factor responsible for these effects was identified as vascular endothelial growth factor (VEGF). Thus, VEGF may play a broader role in the pathogenesis of cancer than was previously thought, and therapeutic blockade of VEGF action may improve prospects for immunotherapy as well as inhibit tumor neovasculature.

Original languageEnglish (US)
Pages (from-to)1096-1103
Number of pages8
JournalNature Medicine
Volume2
Issue number10
DOIs
StatePublished - Oct 1996
Externally publishedYes

Fingerprint

Dendritic Cells
Vascular Endothelial Growth Factor A
Tumors
Tumor Escape
Neoplasms
Immune system
Neoplasm Antigens
Antigen-Presenting Cells
Immunotherapy
Immune System
Cells
Cell Line
human VEGFA protein
Therapeutics

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., ... Carbone, D. P. (1996). Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nature Medicine, 2(10), 1096-1103. https://doi.org/10.1038/nm1096-1096

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. / Gabrilovich, Dmitry I.; Chen, Hailei L.; Girgis, Khaled R.; Cunningham, H. Thomas; Meny, Geralyn M.; Nadaf, Sorena; Kavanaugh, Denise; Carbone, David P.

In: Nature Medicine, Vol. 2, No. 10, 10.1996, p. 1096-1103.

Research output: Contribution to journalArticle

Gabrilovich, DI, Chen, HL, Girgis, KR, Cunningham, HT, Meny, GM, Nadaf, S, Kavanaugh, D & Carbone, DP 1996, 'Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells', Nature Medicine, vol. 2, no. 10, pp. 1096-1103. https://doi.org/10.1038/nm1096-1096
Gabrilovich, Dmitry I. ; Chen, Hailei L. ; Girgis, Khaled R. ; Cunningham, H. Thomas ; Meny, Geralyn M. ; Nadaf, Sorena ; Kavanaugh, Denise ; Carbone, David P. / Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. In: Nature Medicine. 1996 ; Vol. 2, No. 10. pp. 1096-1103.
@article{c4b4e37e4c5a4561b12e708156445145,
title = "Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells",
abstract = "Inadequate presentation of tumor antigens by host professional antigen-presenting cells (APCs), including dendritic cells (DCs), is one potential mechanism for the escape of tumors from the host immune system. Here, we show that human cancer cell lines release a soluble factor or factors that dramatically affect DC maturation from precursors without affecting the function of relatively mature DCs. One factor responsible for these effects was identified as vascular endothelial growth factor (VEGF). Thus, VEGF may play a broader role in the pathogenesis of cancer than was previously thought, and therapeutic blockade of VEGF action may improve prospects for immunotherapy as well as inhibit tumor neovasculature.",
author = "Gabrilovich, {Dmitry I.} and Chen, {Hailei L.} and Girgis, {Khaled R.} and Cunningham, {H. Thomas} and Meny, {Geralyn M.} and Sorena Nadaf and Denise Kavanaugh and Carbone, {David P.}",
year = "1996",
month = "10",
doi = "10.1038/nm1096-1096",
language = "English (US)",
volume = "2",
pages = "1096--1103",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

AU - Gabrilovich, Dmitry I.

AU - Chen, Hailei L.

AU - Girgis, Khaled R.

AU - Cunningham, H. Thomas

AU - Meny, Geralyn M.

AU - Nadaf, Sorena

AU - Kavanaugh, Denise

AU - Carbone, David P.

PY - 1996/10

Y1 - 1996/10

N2 - Inadequate presentation of tumor antigens by host professional antigen-presenting cells (APCs), including dendritic cells (DCs), is one potential mechanism for the escape of tumors from the host immune system. Here, we show that human cancer cell lines release a soluble factor or factors that dramatically affect DC maturation from precursors without affecting the function of relatively mature DCs. One factor responsible for these effects was identified as vascular endothelial growth factor (VEGF). Thus, VEGF may play a broader role in the pathogenesis of cancer than was previously thought, and therapeutic blockade of VEGF action may improve prospects for immunotherapy as well as inhibit tumor neovasculature.

AB - Inadequate presentation of tumor antigens by host professional antigen-presenting cells (APCs), including dendritic cells (DCs), is one potential mechanism for the escape of tumors from the host immune system. Here, we show that human cancer cell lines release a soluble factor or factors that dramatically affect DC maturation from precursors without affecting the function of relatively mature DCs. One factor responsible for these effects was identified as vascular endothelial growth factor (VEGF). Thus, VEGF may play a broader role in the pathogenesis of cancer than was previously thought, and therapeutic blockade of VEGF action may improve prospects for immunotherapy as well as inhibit tumor neovasculature.

UR - http://www.scopus.com/inward/record.url?scp=0029842830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029842830&partnerID=8YFLogxK

U2 - 10.1038/nm1096-1096

DO - 10.1038/nm1096-1096

M3 - Article

C2 - 8837607

AN - SCOPUS:0029842830

VL - 2

SP - 1096

EP - 1103

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 10

ER -